|
1
|
(NCCN) NCCN: Clinical Practice Guidelines
in Oncology. 2016, accessed November 29, 2016.
|
|
2
|
Brennan ME and Houssami N: Evaluation of
the evidence on staging imaging for detection of asymptomatic
distant metastases in newly diagnosed breast cancer. Breast.
21:112–123. 2012. View Article : Google Scholar
|
|
3
|
Albano D, Patti C, La Grutta L, Agnello F,
Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M,
et al: Comparison between whole-body MRI with diffusion-weighted
imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Eur J Radiol. 85:313–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jambor I, Kuisma A, Ramadan S, Huovinen R,
Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari
H, et al: Prospective evaluation of planar bone scintigraphy,
SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI,
including DWI, for the detection of bone metastases in high risk
breast and prostate cancer patients: SKELETA clinical trial. Acta
Oncol. 55:59–67. 2016. View Article : Google Scholar
|
|
5
|
Albano D, Patti C, Lagalla R, Midiri M and
Galia M: Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for
the assessment of bone marrow involvement in patients with newly
diagnosed lymphoma. Journal of magnetic resonance imaging. J Magn
Reson Imaging. 45:1082–1089. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Littooij AS, Kwee TC, Barber I, Granata C,
Vermoolen MA, Enríquez G, Zsíros J, Soh SY, de Keizer B, Beek FJ,
et al: Whole-body MRI for initial staging of paediatric lymphoma:
Prospective comparison to an FDG-PET/CT-based reference standard.
Eur Radiol. 24:1153–1165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park SH, Moon WK, Cho N, Chang JM, Im SA,
Park IA, Kang KW, Han W and Noh DY: Comparison of
diffusion-weighted MR imaging and FDG PET/CT to predict
pathological complete response to neoadjuvant chemotherapy in
patients with breast cancer. Eur Radiol. 22:18–25. 2012. View Article : Google Scholar
|
|
8
|
Heusner TA, Kuemmel S, Koeninger A, Hamami
ME, Hahn S, Quinsten A, Bockisch A, Forsting M, Lauenstein T,
Antoch G, et al: Diagnostic value of diffusion-weighted magnetic
resonance imaging (DWI) compared to FDG PET/CT for whole-body
breast cancer staging. Eur J Nucl Med Mol Imaging. 37:1077–1086.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wehner J, Weissler B, Dueppenbecker PM,
Gebhardt P, Goldschmidt B, Schug D, Kiessling F and Schulz V:
MR-compatibility assessment of the first preclinical PET-MRI insert
equipped with digital silicon photomultipliers. Phys Med Biol.
60:2231–2255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Delso G, Fürst S, Jakoby B, Ladebeck R,
Ganter C, Nekolla SG, Schwaiger M and Ziegler SI: Performance
measurements of the Siemens mMR integrated whole-body PET/MR
scanner. J Nucl Med. 52:1914–1922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Delso G and Ziegler S: PET/MRI system
design. Eur J Nucl Med Mol Imaging. 36(Suppl 1): S86–S92. 2009.
View Article : Google Scholar
|
|
12
|
Yoon HS, Ko GB, Kwon SI, Lee CM, Ito M,
Chan Song I, Lee DS, Hong SJ and Lee JS: Initial results of
simultaneous PET/MRI experiments with an MRI-compatible silicon
photomultiplier PET scanner. J Nucl Med. 53:608–614. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boss A, Bisdas S, Kolb A, Hofmann M,
Ernemann U, Claussen CD, Pfannenberg C, Pichler BJ, Reimold M and
Stegger L: Hybrid PET/MRI of intracranial masses: Initial
experiences and comparison to PET/CT. J Nucl Med. 51:1198–1205.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boss A, Stegger L, Bisdas S, Kolb A,
Schwenzer N, Pfister M, Claussen CD, Pichler BJ and Pfannenberg C:
Feasibility of simultaneous PET/MR imaging in the head and upper
neck area. Eur Radiol. 21:1439–1446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Heacock L, Weissbrot J, Raad R, Campbell
N, Friedman KP, Ponzo F and Chandarana H: PET/MRI for the
evaluation of patients with lymphoma: Initial observations. AJR Am
J Roentgenol. 204:842–848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Drzezga A, Souvatzoglou M, Eiber M, Beer
AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C,
Rummeny EJ, et al: First clinical experience with integrated
whole-body PET/MR: Comparison to PET/CT in patients with oncologic
diagnoses. J Nucl Med. 53:845–855. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buchbender C, Heusner TA, Lauenstein TC,
Bockisch A and Antoch G: Oncologic PET/MRI, part 2: Bone tumors,
soft-tissue tumors, melanoma, and lymphoma. J Nucl Med.
53:1244–1252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buchbender C, Heusner TA, Lauenstein TC,
Bockisch A and Antoch G: Oncologic PET/MRI, part 1: Tumors of the
brain, head and neck, chest, abdomen, and pelvis. J Nucl Med.
53:928–938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huellner MW, Appenzeller P, Kuhn FP,
Husmann L, Pietsch CM, Burger IA, Porto M, Delso G, von Schulthess
GK and Veit-Haibach P: Whole-body nonenhanced PET/MR versus PET/CT
in the staging and restaging of cancers: Preliminary observations.
Radiology. 273:859–869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Catalano OA, Rosen BR, Sahani DV, Hahn PF,
Guimaraes AR, Vangel MG, Nicolai E, Soricelli A and Salvatore M:
Clinical impact of PET/MR imaging in patients with cancer
undergoing same-day PET/CT: Initial experience in 134 patients - a
hypothesis-generating exploratory study. Radiology. 269:857–869.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee SI, Catalano OA and Dehdashti F:
Evaluation of gyneco-logic cancer with MR imaging,
18F-FDG PET/CT, and PET/MR imaging. J Nucl Med.
56:436–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pace L, Nicolai E, Luongo A, Aiello M,
Catalano OA, Soricelli A and Salvatore M: Comparison of whole-body
PET/CT and PET/MRI in breast cancer patients: Lesion detection and
quanti-tation of 18F-deoxyglucose uptake in lesions and
in normal organ tissues. Eur J Radiol. 83:289–296. 2014. View Article : Google Scholar
|
|
23
|
Taneja S, Jena A, Goel R, Sarin R and Kaul
S: Simultaneous whole-body 18F-FDG PET-MRI in primary
staging of breast cancer: A pilot study. Eur J Radiol.
83:2231–2239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aklan B, Paulus DH, Wenkel E, Braun H,
Navalpakkam BK, Ziegler S, Geppert C, Sigmund EE, Melsaether A and
Quick HH: Toward simultaneous PET/MR breast imaging: Systematic
evaluation and integration of a radiofrequency breast coil. Med
Phys. 40:0243012013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dregely I, Lanz T, Metz S, Mueller MF,
Kuschan M, Nimbalkar M, Bundschuh RA, Ziegler SI, Haase A, Nekolla
SG, et al: A 16-channel MR coil for simultaneous PET/MR imaging in
breast cancer. Eur Radiol. 25:1154–1161. 2015. View Article : Google Scholar
|
|
26
|
Catalano OA, Nicolai E, Rosen BR, Luongo
A, Catalano M, Iannace C, Guimaraes A, Vangel MG, Mahmood U,
Soricelli A, et al: Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR
in the evaluation of osseous metastases in breast cancer patients.
Br J Cancer. 112:1452–1460. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lim I, Noh WC, Park J, Park JA, Kim HA,
Kim EK, Park KW, Lee SS, You EY, Kim KM, et al: The combination of
FDG PET and dynamic contrast-enhanced MRI improves the prediction
of disease-free survival in patients with advanced breast cancer
after the first cycle of neoadjuvant chemotherapy. Eur J Nucl Med
Mol Imaging. 41:1852–1860. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baba S, Isoda T, Maruoka Y, Kitamura Y,
Sasaki M, Yoshida T and Honda H: Diagnostic and prognostic value of
pretreatment SUV in 18F-FDG/PET in breast cancer:
Comparison with apparent diffusion coefficient from
diffusion-weighted MR imaging. J Nucl Med. 55:736–742. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miyake KK, Nakamoto Y, Kanao S, Tanaka S,
Sugie T, Mikami Y, Toi M and Togashi K: Journal Club: Diagnostic
value of 18F-FDG PET/CT and MRI in predicting the
clinicopathologic subtypes of invasive breast cancer. AJR Am J
Roentgenol. 203:272–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Galiza Barbosa F, Delso G, Zeimpekis
KG, Ter Voert E, Hüllner M, Stolzmann P and Veit-Haibach P:
Evaluation and clinical quantification of neoplastic lesions and
physiological structures in TOF-PET/MRI and non-TOF/MRI - a pilot
study. Q J Nucl Med Mol Imaging. May 12–2015.Epub ahead of print.
PubMed/NCBI
|
|
31
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: TNM Classification of Malignant Tumours. 7th edition.
Wiley-Blackwell; Chichester: 2010
|
|
32
|
Wetter A, Lipponer C, Nensa F,
Beiderwellen K, Olbricht T, Rübben H, Bockisch A, Schlosser T,
Heusner TA and Lauenstein TC: Simultaneous 18F choline
positron emission tomography/magnetic resonance imaging of the
prostate: Initial results. Invest Radiol. 48:256–262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wetter A, Nensa F, Schenck M, Heusch P,
Pöppel T, Bockisch A, Forsting M, Schlosser TW, Lauenstein TC and
Nagarajah J: Combined PET imaging and diffusion-weighted imaging of
intermediate and high-risk primary prostate carcinomas with
simultaneous [18F] choline PET/MRI. PLoS One.
9:e1015712014. View Article : Google Scholar
|
|
34
|
de Perrot T, Rager O, Scheffler M, Lord M,
Pusztaszeri M, Iselin C, Ratib O and Vallee JP: Potential of hybrid
18F-fluorocholine PET/MRI for prostate cancer imaging.
Eur J Nucl Med Mol Imaging. 41:1744–1755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grueneisen J, Beiderwellen K, Heusch P,
Gratz M, Schulze-Hagen A, Heubner M, Kinner S, Forsting M,
Lauenstein T, Ruhlmann V, et al: Simultaneous positron emission
tomography/magnetic resonance imaging for whole-body staging in
patients with recurrent gynecological malignancies of the pelvis: A
comparison to whole-body magnetic resonance imaging alone. Invest
Radiol. 49:808–815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grueneisen J, Schaarschmidt BM,
Beiderwellen K, Schulze-Hagen A, Heubner M, Kinner S, Forsting M,
Lauenstein T, Ruhlmann V and Umutlu L: Diagnostic value of
diffusion-weighted imaging in simultaneous 18F-FDG
PET/MR imaging for whole-body staging of women with pelvic
malignancies. J Nucl Med. 55:1930–1935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Souvatzoglou M, Eiber M, Takei T, Fürst S,
Maurer T, Gaertner F, Geinitz H, Drzezga A, Ziegler S, Nekolla SG,
et al: Comparison of integrated whole-body [11C]choline
PET/MR with PET/CT in patients with prostate cancer. Eur J Nucl Med
Mol Imaging. 40:1486–1499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Selzner M, Morse MA, Vredenburgh JJ,
Meyers WC and Clavien PA: Liver metastases from breast cancer:
Long-term survival after curative resection. Surgery. 127:383–389.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vogl TJ, Naguib NNN, Nour-Eldin N-EA, Mack
MG, Zangos S, Abskharon JE and Jost A: Repeated chemoembolization
followed by laser-induced thermotherapy for liver metastasis of
breast cancer. AJR Am J Roentgenol. 196:W66–W72. 2011. View Article : Google Scholar
|
|
40
|
Alexander E III, Moriarty TM, Davis RB,
Wen PY, Fine HA, Black PM, Kooy HM and Loeffler JS: Stereotactic
radiosurgery for the definitive, noninvasive treatment of brain
metastases. J Natl Cancer Inst. 87:34–40. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen YM, Huang G, Sun XG, Liu JJ, Chen T,
Shi YP and Wan LR: Optimizing delayed scan time for FDG PET:
Comparison of the early and late delayed scan. Nucl Med Commun.
29:425–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng G, Torigian DA, Zhuang H and Alavi
A: When should we recommend use of dual time-point and delayed
time-point imaging techniques in FDG PET? Eur J Nucl Med Mol
Imaging. 40:779–787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Laffon E, de Clermont H, Begueret H,
Vernejoux JM, Thumerel M, Marthan R and Ducassou D: Assessment of
dual-time-point 18F-FDG-PET imaging for pulmonary
lesions. Nucl Med Commun. 30:455–461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Atkinson W, Catana C, Abramson JS, Arabasz
G, McDermott S, Catalano O, Muse V, Blake MA, Barnes J, Shelly M,
et al: Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma
patients. Abdom Radiol (NY). 41:1338–1348. 2016. View Article : Google Scholar
|
|
45
|
Pujara AC, Raad RA, Ponzo F, Wassong C,
Babb JS, Moy L and Melsaether AN: Standardized uptake values from
PET/MRI in metastatic breast cancer: An organ-based comparison with
PET/CT. Breast J. 22:264–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Boellaard R, O'Doherty MJ, Weber WA,
Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J,
Hoekstra OS, Pruim J, et al: FDG PET and PET/CT: EANM procedure
guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol
Imaging. 37:181–200. 2010. View Article : Google Scholar
|
